Advisory bodies

Regulatory and advisory bodies publish methods for ambient air analysis sueh as those issued by the British Standards Institute and the US Environment Proteetion Ageney (Tables 10.24 and 10.25, respeetively). Methods for assessment of workplace air are published by the Health and Safety Exeeutive. Some of these are generie methods (Table 10.26) whilst others are eompound speeifie (Table 10.27). Examples of other offieial methods for monitoring workplaee air quality are those published by the British Standards Institute (Table 10.28), and the US National Institute of Oeeupational Safety and Health (Table 10.29). Table 10.30 provides additional guidanee on analytieal teehniques for a seleetion of substanees. 

The Japanese regulatory authority is the Ministry of Health and Welfare (MHW) and the Pharmaceutical and Medical Safety Bureau (PSMB) is responsible for the promulgation of national and international guidelines in the form of Notifications. Guidelines are available on the Internet web-site of the National Institute of Health and Science (http //www.nihs.go.jp). The MHW has not issued specific guidance on the development of chiral drugs, but has nonetheless responded to the enantiomer-versus-racemate scientific debate. The attitude of the MHW and its advisory body, the Central Pharmaceutical Affairs Council (CPAC) is discussed in two articles by Shindo and Caldwell published in 1991 and 1995 [17, 18]. The latter paper analyzes the results of a survey of the Japanese pharmaceutical industry which sought responses on chirality issues. 

Regulatory and advisory bodies publish methods for ambient air analysis such as those from HSE, the British Standards Institution and NIOSH listed in Table 9.12. Table 9.13 provides additional data on analytical techniques for a selection of substances. 

Preliminary work on several of these projects has already been in progress for over a year. These initial efforts will be expanded and intensified when the committee on pesticides becomes activated in the near future. However, pursuance of this program will require the support and cooperation of all segments of science and industry. Advisory bodies from the various interested groups will be called upon for recommendations and suggestions on problems which fall within their field. In turn, the assistance of this committee will be available, not only to the medical profession, but to all other groups in any direction in which the committee may be useful. 

Following further consideration and consultations, the Joint Subcommittee proposed to formulate detailed advice on the composition and terms of this expert advisory body. On 6 November 1962, the Minister of Health aimounced that the Government had accepted the first two recommendations and would await the advice on the third. 

In 2002, the Parliamentary Secretary to the Treasurer requested the Productivity Commission, the government s review and advisory body on microeconomic policy and regulation, to investigate the rationale, effectiveness and efficiency of the programme. The commission s report recommended that there should be a programme to follow PUP but that it should be modified to be oriented to reward only R D investment, not production value-adding activity. 

JECFA is a scientific advisory body established in tire 1950s, prior to the establishment of the CAC. Over the past 40 years, it has provided independent scientific advice to all FAO and WHO member countries. The traditional and current activities of JECFA are mainly in the area of risk assessment, not risk management. To some extent, however, JECFA activities also touch on risk management. Risk assessment, risk management, and risk communication constitute the three basic elements of risk analysis that are taken into account in the Codex procedure for setting MRLs of veterinary drug residues in foods (Table 11.1). 

IFRA International Fragrance Association. An advisory body for safety of materials. 

Commitee for Proprietory Midicinial Products (CPMP) Advisory body for EMEA releases general guidelines regulating pharmaceutical production Same as EMEA... 

The Executive Board is the advisory body of the Medicines Commission. It consists of a chairman, a vice chairman and eight other members. The chairman is a professor in medicines and the vice chairman is a professor in pharmacy. One of the members is a general practitioner, four are professors in pharmacology with a specialisation in pharmacognosy and pharmacology and the other two are professors in galenics. The last is a professor in veterinary science. Nominations for these posts are made through a Royal Decree. 

The restructured Portuguese approvals advisory body, the Technical Medicines Committee (CTM) was established in June 1996 cind INFARMED expected that the increase in the number of committee members, which doubled to almost 60 would mean it could operate more quickly and efficiently, in line with EU requirements. However, the average approval time in Portugcil is still three to four years though INFARMED says that the average time for new products is less than one year while... 

Committee membership is voluntary and without remuneration. A declaration of interests is made annually by all members excepting the British Pharmacopoeia Commission (whose work does not necessitate such declaration). The declarations are published in the Annual Reports of the Medicines Act 1968 Advisory Bodies, listing consultancies and research interests. 

---